Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 2006
c4d66e80-f0bc-4e64-a0f0-630ef673da1b
HUMAN PRESCRIPTION DRUG LABEL
Mar 6, 2023
Par Pharmaceutical, Inc.
DUNS: 092733690
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Product Details
FDA regulatory identification and product classification information